155 related articles for article (PubMed ID: 34602609)
1. The ethical landscape(s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review.
Perrot A; Horn R
Eur J Hum Genet; 2022 Jun; 30(6):676-681. PubMed ID: 34602609
[TBL] [Abstract][Full Text] [Related]
2. Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France.
Bowman-Smart H; Perrot A; Horn R
BMC Med Ethics; 2024 Mar; 25(1):34. PubMed ID: 38515078
[TBL] [Abstract][Full Text] [Related]
3. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive prenatal testing in Germany: a unique ethical and policy landscape.
Bowman-Smart H; Wiesemann C; Horn R
Eur J Hum Genet; 2023 May; 31(5):562-567. PubMed ID: 36509835
[TBL] [Abstract][Full Text] [Related]
5. Preserving women's reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany.
Perrot A; Horn R
J Med Ethics; 2023 Jul; 49(7):471-473. PubMed ID: 35347082
[TBL] [Abstract][Full Text] [Related]
6. Health professionals and scientists' views on genome-wide NIPT in the French public health system: Critical analysis of the ethical issues raised by prenatal genomics.
Perrot A; Horn R
PLoS One; 2022; 17(11):e0277010. PubMed ID: 36318580
[TBL] [Abstract][Full Text] [Related]
7. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
Zhytnik L; Peters M; Tilk K; Simm K; Tõnisson N; Reimand T; Maasalu K; Acharya G; Krjutškov K; Salumets A
Hum Reprod Update; 2021 Oct; 27(6):1056-1085. PubMed ID: 34329448
[TBL] [Abstract][Full Text] [Related]
8. Implementation challenges for an ethical introduction of noninvasive prenatal testing: a qualitative study of healthcare professionals' views from Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
BMC Med Ethics; 2020 Feb; 21(1):15. PubMed ID: 32041603
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
[TBL] [Abstract][Full Text] [Related]
10. Unfair discrimination in prenatal aneuploidy screening using cell-free DNA?
Rolfes V; Schmitz D
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():27-29. PubMed ID: 26773245
[TBL] [Abstract][Full Text] [Related]
11. An assessment of the analytical performance of non-invasive prenatal testing (NIPT) in detecting sex chromosome aneuploidies: 34,717-patient sample in a single prenatal diagnosis Centre in China.
Luo Y; Hu H; Zhang R; Ma Y; Pan Y; Long Y; Hu B; Yao H; Liang Z
J Gene Med; 2021 Sep; 23(9):e3362. PubMed ID: 33973298
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening: current practice, new developments, ethical challenges.
de Jong A; Maya I; van Lith JM
Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
[TBL] [Abstract][Full Text] [Related]
13. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec.
Haidar H; Vanstone M; Laberge AM; Bibeau G; Ghulmiyyah L; Ravitsky V
AJOB Empir Bioeth; 2018; 9(2):99-111. PubMed ID: 29847254
[TBL] [Abstract][Full Text] [Related]
14. [Bioethical dilemmas in prenatal diagnosis: non-invasive prenatal test and new technologies].
Sánchez Marín JP; García González E
Cuad Bioet; 2023; 34(111):219-232. PubMed ID: 37804493
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
16. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
17. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
[TBL] [Abstract][Full Text] [Related]
19. Chromosome Screening Using Noninvasive Prenatal Testing Beyond Trisomy-21: What to Screen for and Why It Matters.
Hens K
J Med Philos; 2018 Jan; 43(1):8-21. PubMed ID: 29300981
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
